Positron emission tomography with fluorine-deoxyglucose in sarcomas and non-sarcoma non-epithelial tumors Utilidad del estudio PET con FDG en la evaluación de sarcomas de diverso origen y de tumores no sarcoma-no epiteliales
Author
dc.contributor.author
Vega, Teresa Massardo
Author
dc.contributor.author
Jofré, María Josefina
Author
dc.contributor.author
Sierralta, María Paulina
Author
dc.contributor.author
Canessa, José
Author
dc.contributor.author
Castro, Gabriel
Author
dc.contributor.author
Berrocal, Isabel
Author
dc.contributor.author
Gallegos, Iván
Admission date
dc.date.accessioned
2019-03-15T16:03:44Z
Available date
dc.date.available
2019-03-15T16:03:44Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 140, Issue 9, 2018, Pages 1116-1125
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.other
10.4067/S0034-98872012000900003
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165898
Abstract
dc.description.abstract
Background: The usefulness of positron emission tomography (PET) with fluorine-deoxyglucose (FDG) in sarcomas and non-sarcoma non-epithelial (NSNE) tumors is not clearly defined. Aim: To report a Chilean experience with NSNE tumors evaluated using PET with FDG. Material and Methods: Retrospective review of the database of a PET laboratory. Demographic data, indications and metabolic findings were compared with conventional imaging in 88 adults and children with diverse bone and soft tissue sarcomas as well as 24 gastrointestinal stromal tumors (GIST), 6 pleural malignant mesotheliomas in adults, and 9 medulloblastomas in children. Results: FDG showed good concordance with conventional imaging in NSNE tumors. It was helpful for staging, restaging, follow-up after treatment and for the detection of new not previously suspected lesions. Conclusions: PET with FDG could have a prognostic role and help in patient management, mainly in musculoskeletal and high grade or less differentiated sar
Positron emission tomography with fluorine-deoxyglucose in sarcomas and non-sarcoma non-epithelial tumors Utilidad del estudio PET con FDG en la evaluación de sarcomas de diverso origen y de tumores no sarcoma-no epiteliales
Mutations in fused in sarcoma and/or translocated in liposarcoma (FUS, TLS or FUS) are linked to familial
cases of amyotrophic lateral sclerosis (ALS). Mutant FUS selectively accumulates into discrete cytosolic
structures ...
Gac Espinoza, Patricio; Cabané Toledo, Patricio; Gallegos Méndez, Iván; Abusleme P., Eugenia; Ortúzar E., Waldo; Amat Vidal, José; Marambio R., Andrés; Martínez G., Felipe; Miranda V., Carolina(2008-08)
El sarcoma sinovial es un tumor maligno de partes blandas, bien diferenciado y que representa entre
5.6% a 10% de todos los sarcomas. Su localización en cabeza y cuello no es común, y representa cerca
de un 9%, con menos ...